Serotonergic function and suicidal behavior in schizophrenia

Abel, 1996, Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients, Br. J. Psychiatry, 168, 57, 10.1192/bjp.168.1.57 Abel, 1997, Serotonergic function and negative and depressive symptomatology in Schizophrenia and major depression, Psychoneuroendocrinology, 22, 539, 10.1016/S0306-4530(97)00050-4 Allebeck, 1989, Schizophrenia: a life-shortening disease, Schizophrenia Bull., 15, 81, 10.1093/schbul/15.1.81 Allebeck, 1987, Risk factors for suicide among patients with schizophrenia, Acta Psychiatr. Scand., 76, 414, 10.1111/j.1600-0447.1987.tb05626.x Asberg, 1981, Studies of CSF-5-HIAA in depression and suicidal behavior, Adv. Exp. Med. Biol., 133, 739, 10.1007/978-1-4684-3860-4_41 Asberg, 1976, 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor?, Arch. Gen. Psychiatry, 33, 1193, 10.1001/archpsyc.1976.01770100055005 Beautrais, 1996, Prevalence and co morbidity of mental disorders in persons making serious suicide attempts: a case control study, Am. J. Psychiatry, 153, 1009, 10.1176/ajp.153.8.1009 Beck, 1975, Classification of suicidal behaviors I. Quantifying intent and medical lethality, Am. J. Psychiatry, 132, 285, 10.1176/ajp.132.3.285 Brent, 1996, Suicidal behavior runs in families, Arch. Gen. Psychiatry, 53, 1145, 10.1001/archpsyc.1996.01830120085015 Brown, 1979, Aggression in humans correlates with cerebrospinal fluid amine metabolism, Psychiatry Res., 1, 131, 10.1016/0165-1781(79)90053-2 Brown, 1982, Aggression, suicide, and serotonin: relationships to CSF amine metabolites, Am. J. Psychiatry, 139, 741, 10.1176/ajp.139.6.741 Caldwell, 1992, Schizophrenia — a high-risk factor for suicide: clues to risk reduction, Suicide and Life Threat. Behav., 22, 479, 10.1111/j.1943-278X.1992.tb01040.x Cleare, 1996, Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects, Neuropsychopharmacology, 14, 349, 10.1016/0893-133X(95)00144-3 Coccaro, 1994, PRL and HVA responses to d- and d,l-fenfluramine in humans, Biol. Psychiatry, 35, 64, 10.1016/0006-3223(94)90764-1 Coccaro, 1989, Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior, Arch. Gen. Psychiatry, 46, 587, 10.1001/archpsyc.1989.01810070013002 Cooper, 1992, 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behavior in schizophrenia, Lancet, 340, 940, 10.1016/0140-6736(92)92819-2 Correa, 2000, Prolactin response to d-fenfluramine and suicidal behavior in depressed patients, Psychiatry Res., 93, 189, 10.1016/S0165-1781(00)00114-1 Diekstra, 1993, The epidemiology of suicide and para suicide, Acta Psychiatr. Scand., 371, 6 Diekstra, 1996, Epidemiologie du suicide, L'Encephale Sp, IV, 15 Dorpat, 1960, A study of suicide in the Seattle area, Comp. Psychiatry, 1, 349, 10.1016/S0010-440X(60)80058-2 Duval, 1994, Endocrine responses to dl- and d-fenfluramine in psychiatry, Biol. Psychiatry, 35, 646, 10.1016/0006-3223(94)90772-2 Duval, 1997, Hormonal responses to Dextro-fenfluramine in major depressive episode, Biol. Psychiatry, 41, 61 Garattini, 1987, From fenfluramine racemate to d-fenfluramine, Ann. N. Y. Acad. Sci., 499, 156, 10.1111/j.1749-6632.1987.tb36207.x Goldstein, 1991, The prediction of suicide. Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders, Arch. Gen. Psychiatry, 48, 418, 10.1001/archpsyc.1991.01810290030004 Goodal, 1993, Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers, Psychopharmacoloy, 112, 461, 10.1007/BF02244895 Goodwin, 1994, Oral d-fenfluramine and neuroendocrine challenge: problems with a the 30mg dose in men, J. Affect. Disord., 30, 117, 10.1016/0165-0327(94)90039-6 Gudelsky, 1984, Dopaminergic and serotonergic control of neuroendocrine function, Monographs Neural Sci., 10, 85 Hagnell, 1981, Suicide rates in the Lundbly study: mental illness as a risk factor for suicide, Neuropsychobiology, 7, 248, 10.1159/000117857 Hamilton, 1960, A rating scale for depression, J Neurol. Neurosurg. Psychiatr., 23, 56, 10.1136/jnnp.23.1.56 Harkavy-Friedman, 1997, Assessement and intervention for the suicidal patient with schizophrenia, Psychiat. Q., 68, 361, 10.1023/A:1025447115067 Higley, 1993, Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamone metabolites in rhesus monkeys (Macaca mulata), Arch. Gen. Psychiat., 50, 615, 10.1001/archpsyc.1993.01820200025003 Hogarty, 1995, Pharmacology of impaired affect in recovering schizophrenic patients, Arch. Gen. Psychiat., 52, 29, 10.1001/archpsyc.1995.03950130029004 Invernizzi, 1986, d- and l-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat, Eur. J. Pharmacol., 120, 9, 10.1016/0014-2999(86)90633-3 Johns, 1986, Suicide in schizophrenia, Ann. N. Y. Acad. Sci., 487, 294, 10.1111/j.1749-6632.1986.tb27908.x Kasper, 1990, Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment, Pharmacopsychiat., 23, 76, 10.1055/s-2007-1014487 Kavoussi, 1998, Prolactin response to d-fenfluramine in outpatients with major depression, Psychiat. Res., 79, 199, 10.1016/S0165-1781(98)00039-0 Leibenluft, 1994, Effects of the menstrual cycle on dependent variables in mood disorder research, Arch. Gen. Psychiat., 51, 761, 10.1001/archpsyc.1994.03950100009002 Leon, 1990, Statistical issues in the identification of risk factors for suicidal behavior: the application of survival analysis, Psychiat. Res., 31, 99, 10.1016/0165-1781(90)90112-I Linkowski, 1985, Suicidal behaviour in major depressive illness, Acta Psychiatr. Scand., 72, 233, 10.1111/j.1600-0447.1985.tb02600.x Lopez-Ibor, 1985, Biological correlations of suicide and aggressivity in major depressions (with melancholia): 5-hydroxyindoleacetic acid and cortisol in cerebral spinal fluid, dexamethasone suppression test and therapeutic response to 5-hydroytryptophan, Neuropsychobiology, 14, 67, 10.1159/000118207 Lopez-Ibor, 1988, The fenfluramine challenge test in the affective spectrum: a possible marker of endogenicity and severity, Pharmacopsychiatry, 21, 9, 10.1055/s-2007-1014638 Maes, 1991, HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls, Prog. Neuro-Psychopharmacol. Biol. Psychiat., 15, 781, 10.1016/0278-5846(91)90007-N Malone, 1996, Prolactin response to fenfluramine and suicide lethality in major depression, Br. J. Psychiat., 168, 324, 10.1192/bjp.168.3.324 Mann, 1989, Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies, Br. J. Psychiat., 155, 7, 10.1192/S000712500029171X Mann, 1996, Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients, Am. J. Psychiat., 153, 174 Mann, 1997, Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients, Biol. Psychiat., 41, 162, 10.1016/S0006-3223(96)00217-X Mann, 1997, Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients, Am. J. Psychiat., 154, 1451, 10.1176/ajp.154.10.1451 Mann, 1992, Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients, Arch. Gen. Psychiat., 49, 442, 10.1001/archpsyc.1992.01820060022003 Mann, 1986, Increased serotonin and adrenergic receptor binding in the frontal cortices of suicide victims (1986), Arch. Gen. Psychiat., 43, 954, 10.1001/archpsyc.1986.01800100048007 Meyer, 1998, No effect of depression on [15O]H2O PET response to intravenous d-fenfluramine, Am. J. Psychiat., 155, 1241, 10.1176/ajp.155.9.1241 Mohr, 1998, Prolactin response to d-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia, Schizophr. Res., 30, 91, 10.1016/S0920-9964(97)00124-2 Mohr, 1999, Effects of haloperidol treatment on prolactin response to d-fenfluramine challenge in acute schizophrenia, Psychopharmacology, 141, 322, 10.1007/s002130050840 Mokrani, 1995, Multihormonal responses to apomorphine in mental illness, Psychoneuroendocrinology, 20, 365, 10.1016/0306-4530(94)00065-4 Monteleone, 1999, Prolactin hyperresponsiveness to d-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study, Biol. Psychiat., 45, 1606, 10.1016/S0006-3223(98)00270-4 Montgomery, 1982, Pharmacological prevention of suicidal behavior, J. Affect. Disord., 4, 291, 10.1016/0165-0327(82)90026-X Nielsen, 1994, Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism, Arch. Gen. Psychiat., 51, 34, 10.1001/archpsyc.1994.03950010034005 Nielsen, 1998, A tryptophan hydroxylase gene marker for suicidality and alcoholism, Arch. Gen. Psychiat., 55, 593, 10.1001/archpsyc.55.7.593 Ninan, 1984, CSF 5-hydroxyindoleacetic acid levels in suicidal schizophenic patients, Am. J. Psychiat., 141, 566, 10.1176/ajp.141.4.566 Nordstrom, 1994, CSF 5-HIAA predicts suicide risk after attempt suicide, Suicide Life Threatening Behav., 24, 1, 10.1111/j.1943-278X.1994.tb00657.x O'keane, 1991, Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function, Am. J. Psychiat., 14, 1009 Overall, 1962, The brief psychiatric rating scale, Psychol. Rep., 10, 799, 10.2466/pr0.1962.10.3.799 Palazidou, 1995, Evidence for 5-HT1A receptor involvement in the control of prolactin secretion in man, Psychopharmacoloy, 119, 311, 10.1007/BF02246297 Park, 1996, 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to d-fenfluramine, Psychol. Med., 26, 1191, 10.1017/S0033291700035911 Pfeffer, 1994, Suicidal children grow-up: suicidal behavior and psychiatric disorders among relatives, J. Am. Acad. Chlid. Adolescent Psychiat., 33, 1087, 10.1097/00004583-199410000-00004 Porkony, 1983, Prediction of suicide in psychiatric patients: a report of a prospective study, Arch. Gen. Psychiat., 40, 249, 10.1001/archpsyc.1983.01790030019002 Radomsky, 1999, Suicidal behavior in patients with schizophrenia and other psychotic disorders, Am. J. Psychiat., 156, 1590, 10.1176/ajp.156.10.1590 Roy, 1982, Risk factors for suicide in psychiatric patients, Arch. Gen. Psychiat., 39, 1089, 10.1001/archpsyc.1982.04290090071014 Roy, 1983, Family history of suicide, Arch. Gen. Psychiat., 40, 971, 10.1001/archpsyc.1983.01790080053007 Roy, 1989, Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow up study, Arch. Gen. Psychiat., 46, 609, 10.1001/archpsyc.1989.01810070035005 Roy, 1997, Genetics of suicide: family and molecular genetics, Ann. N.Y. Acad. Sci., 836, 135, 10.1111/j.1749-6632.1997.tb52358.x Roy, 1986, Suicidal behavior in chronic schizophrenic patients: a follow-up study, Can. J. Psychiat., 31, 737, 10.1177/070674378603100808 Siever, 1999, d,l-Fenfluramine response in impulsive personality disorder assessed with [18F] fluorodeoxyglucose positron emission tomography, Neuropsychopharmacology, 20, 413, 10.1016/S0893-133X(98)00111-0 Sisook, 1999, Depressive symptoms in schizophrenia, Am. J. Psychiatry, 156, 1736, 10.1176/ajp.156.11.1736 Spitzer, 1975 Van Prag, 1982, Depression, suicide and the metabolism of serotonin in the brain, J. Affect. Disord., 4, 275, 10.1016/0165-0327(82)90025-8 Van Praag, 1983, CSF 5-HIAA and suicide in non-depressed schizophrenics, Lancet, 2, 977, 10.1016/S0140-6736(83)90501-9